1. Home
  2. HNNA vs COEP Comparison

HNNA vs COEP Comparison

Compare HNNA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hennessy Advisors Inc.

HNNA

Hennessy Advisors Inc.

HOLD

Current Price

$10.10

Market Cap

78.0M

Sector

Finance

ML Signal

HOLD

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$16.40

Market Cap

91.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNNA
COEP
Founded
1989
2017
Country
United States
United States
Employees
N/A
6
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
91.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HNNA
COEP
Price
$10.10
$16.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.8K
60.9K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
5.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.77
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.90
$6.80
52 Week High
$13.19
$21.41

Technical Indicators

Market Signals
Indicator
HNNA
COEP
Relative Strength Index (RSI) 59.30 72.18
Support Level $9.66 $13.77
Resistance Level $10.33 $19.19
Average True Range (ATR) 0.14 1.15
MACD 0.03 0.47
Stochastic Oscillator 90.08 87.62

Price Performance

Historical Comparison
HNNA
COEP

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company that manages and markets open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, multi-asset sectors, specialty products, and fixed income products. The company earns revenues mainly from investment advisory services and secondarily from shareholder services. Advisory services include managing each fund's portfolio in line with its investment objectives, monitoring compliance and performance, overseeing sub-advisors and other service providers, and handling marketing, distribution, and regulatory reporting. Shareholder services cover investor support and coordination with the fund service provider, with all related fees based on the funds' average daily net asset values.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Share on Social Networks: